Laurent Faveriel

Title: The Innovations of Laurent Faveriel

Introduction

Laurent Faveriel is a notable inventor based in Longjumeau, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that activate AMPK (AMP-activated protein kinase). With a total of 2 patents, his work focuses on therapeutic applications that address various health disorders.

Latest Patents

Faveriel's latest patents include innovative compounds that serve as direct activators of AMPK. The first patent, titled "Thieno [2,3-B] pyridinedione activators of AMPK and therapeutic uses thereof," describes compounds that can be utilized in the treatment of disorders regulated by AMPK activation. These disorders include diabetes, metabolic syndrome, obesity, inflammation, cancer, and cardiovascular diseases. The second patent, "Thienopyridone derivatives useful as activators of AMPK," also outlines compounds that can treat a range of conditions such as liver disease, hepatic steatosis, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steato-hepatitis (NASH), among others.

Career Highlights

Laurent Faveriel is currently associated with Poxel, a company that focuses on developing innovative treatments for metabolic diseases. His expertise in AMPK activators has positioned him as a key figure in the research and development of new therapeutic options.

Collaborations

Faveriel collaborates with esteemed colleagues such as Daniel Cravo and Sophie Hallakou-Bozec. Their combined efforts contribute to advancing the understanding and application of AMPK activators in medical science.

Conclusion

Laurent Faveriel's work exemplifies the impact of innovative research in the field of medicinal chemistry. His patents and collaborations highlight the potential for new treatments that can significantly improve health outcomes for various diseases.